IRONWOOD PHARMACEUTICALS INC's ticker is and the CUSIP is 46333XAD0. A total of 23 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $9,332,000 | -1.2% | 9,000 | 0.0% | 0.80% | +28.6% |
Q4 2021 | $9,445,000 | -3.7% | 9,000 | 0.0% | 0.63% | -21.4% |
Q3 2021 | $9,804,000 | -1.5% | 9,000 | 0.0% | 0.80% | -3.7% |
Q2 2021 | $9,953,000 | +361.4% | 9,000 | +350.0% | 0.83% | +386.5% |
Q1 2021 | $2,157,000 | – | 2,000 | – | 0.17% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Opti Capital Management, LP | 11,901 | $11,946,000 | 2.07% |
Context Capital Management, LLC | 1,000,000 | $997,000 | 0.56% |
WOLVERINE ASSET MANAGEMENT LLC | 33,392,000 | $33,442,000 | 0.42% |
SSI INVESTMENT MANAGEMENT LLC | 3,000,000 | $2,991,000 | 0.22% |
CSS LLC/IL | 2,876,000 | $2,883,000 | 0.18% |
PALISADE CAPITAL MANAGEMENT, LP | 5,000,000 | $5,016,000 | 0.15% |
HBK INVESTMENTS L P | 10,116,000 | $10,186,000 | 0.13% |
TENOR CAPITAL MANAGEMENT Co., L.P. | 1,817,000 | $1,835,000 | 0.11% |
LINDEN ADVISORS LP | 6,269,000 | $6,290,000 | 0.08% |
LAZARD ASSET MANAGEMENT LLC | 15,000,000 | $15,028,000 | 0.02% |